Tag: Cancer: Bladder
Recovery From Radical Cystectomy Takes Three to Six Months
No difference seen in percentage of patients recovering at each time point for robot-assisted versus open radical cystectomy
Carbogen and Nicotinamide With Radiation Feasible for Bladder Cancer
Trial involving seven patients with locally advanced bladder cancer shows concurrent CON with radiation therapy feasible in Australia
Adjuvant Nivolumab Slows Muscle-Invasive Urothelial Carcinoma
Disease-free survival was longer with adjuvant nivolumab in intention-to-treat population, for those with PD-L1 expression at least 1 percent
Enfortumab Vedotin Prolongs Survival in Advanced Urothelial Cancer
Overall survival longer compared with standard chemo for disease progression following platinum-based chemo and PD-1 or PD-L1 inhibitor
Aspirin Use Tied to Longer Bladder, Breast Cancer Survival
However, aspirin use in older adults not tied to incidence of various cancer types
Smoking Tied to Worse Bladder Cancer Outcomes After Surgery
Poor outcomes include lower response rate to chemotherapy, higher mortality, recurrence
Avelumab Prolongs Survival in Advanced Urothelial Cancer
Findings seen in patients with advanced, metastatic disease that did not progress with first-line chemo
High BMI in Childhood May Up Risk for Bladder Cancer as Adult
Height inversely linked to bladder cancer, while excess BMI gain in childhood linked to increased risk
Addition of Atezolizumab May Aid in Metastatic Urothelial Cancer
Phase 3 trial shows prolonged progression-free survival for atezolizumab plus platinum-based chemo
FDA Labeling Restriction Quickly Reflected in Oncology Practice
FDA label change linked to decrease in immunotherapy use, increases in chemotherapy use, PD-L1 testing
